Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Sandlot scores endorsement by one of KC’s favorite players; how the deal puts this brand on a base path to the big leagues
Kansas City’s only local hat maker, Sandlot Goods, announced Thursday its first professional athlete endorsement — from Royals infielder Nicky Lopez — in a hit aimed as a major play in the brand’s home run strategy. “We are incredibly excited about our first major league endorsement,” said Chad Hickman, founder of Sandlot Goods. “The first…
Despise doggie duty? It’s only No. 10 on startup’s list of pet peeve tasks people don’t want to do themselves
One in four Kansas City residents say they’ve become worse at handling awkward tasks since the pandemic began, according to a new survey by local services marketplace Airtasker. Among the most biting tasks KC wants to avoid: picking up dog poop from someone else’s lawn. Airtasker, which acquired Kansas City-based startup Zaarly in May 2021,…
Overland Park startup wins four pilot projects through NXTUS health competition
Startland News’ Startup Road Trip series explores innovative and uncommon ideas finding success in rural America and Midwestern startup hubs outside the Kansas City metro. This series is possible thanks to the Ewing Marion Kauffman Foundation, which leads a collaborative, nationwide effort to identify and remove large and small barriers to new business creation. WICHITA…
Inside-the-box thinking: Veteran entrepreneurs craft memory care tools to engage dementia patients
The founders of one of Kansas City’s celebrated small businesses are launching a new solution for dementia care: a curated, monthly subscription box full of themed engagement activities and tools designed to improve patients’ quality of life. Prairie Elder Care’s Michala Gibson and Mandy Shoemaker originated the idea for the Connectivities subscription tool during the…